11-epi-Sinulariolide Acetate-induced Apoptosis in Oral Cancer Cells Is Regulated by FOXO Through Inhibition of

Ting-Shou Chang1,2,3, Jen-Jie Lin4, Kai-Chun Cheng5,6,7

  • 1Department of Otolaryngology-Head and Neck Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, R.O.C.

Anticancer Research
|May 29, 2023
PubMed
Abstract

Insights

11-epi-sinulariolide acetate (11-epi-SA) induces apoptosis in oral cancer cells by inhibiting the PI3K/AKT/FOXO pathway. This compound shows promise as a novel therapeutic agent for oral cancer treatment.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Oncology

Background:

  • Oral cancer, primarily squamous cell carcinoma, is a significant health concern in Taiwan, particularly among males, due to its high mortality rate.
  • 11-epi-sinulariolide acetate (11-epi-SA), a compound isolated from Sinularia flexibilis, has not been previously investigated for its anticancer effects on oral cancer.

Purpose of the Study:

  • To investigate the in vitro anticancer activity of 11-epi-SA against the CAL-27 oral cancer cell line.
  • To elucidate the molecular mechanisms underlying 11-epi-SA-induced apoptosis in oral cancer cells.

Main Methods:

  • MTT assay for cell proliferation inhibition.
  • Morphological analysis, DNA fragmentation, TUNEL/DAPI, and JC-1 staining to assess apoptosis.
  • Western blot analysis to investigate key apoptotic pathway proteins.

Main Results:

  • 11-epi-SA demonstrated significant inhibition of CAL-27 oral cancer cell proliferation.
  • The compound induced apoptosis via the PI3K/AKT/FOXO signaling pathway, leading to FOXO nuclear translocation.
  • 11-epi-SA disrupted mitochondrial homeostasis and activated caspase-3 and caspase-9, key executioners of apoptosis.

Conclusions:

  • 11-epi-SA effectively induces apoptosis in oral cancer cells at low concentrations through the PI3K/AKT/FOXO pathway.
  • 11-epi-SA exhibits considerable potential as a novel therapeutic candidate for oral cancer treatment.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.5K